Diagnostics, 2022
Proteomic Analysis of Pleural Effusions from COVID-19 Deceased Patients: Enhanced Inflammatory Markers

Razaghi A., Szakos A., Alouda M. et al.

Clinical Proteomics, 2022
Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay

Christensen T., Maag E., Madsen K. et al.

Nature Aging, 2022
CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels

del Campo M., Peeters C., Johnson E. et al.

European Heart Journal Open, 2022
NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients

Rossignol P., Duarte K., Bresso E. et al.

Human Molecular Genetics, 2022
Identifying causal serum protein–cardiometabolic trait relationships using whole genome sequencing

Png G., Gerlini R., Hatzikotoulas K. et al.

BMJ Open Diabetes Research & Care, 2022
Pregnancy induces pancreatic insulin secretion in women with long-standing type 1 diabetes

Espes D., Magnusson L., Caballero-Corbalan J. et al.

Obesity, 2022
The inflammatory proteome, obesity, and medical weight loss and regain in humans

Perry A., Tanriverdi K., Risitano A. et al.

Clinical and Translational Science, 2022
ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study

Mi J., Wu X., Bai X. et al.

Journal of Clinical Immunology, 2022
Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients

Ebihara T., Matsubara T., Togami Y. et al.

PLOS ONE, 2022
Protein biomarker profiles in serum and CSF in 158 patients with PTLDS or persistent symptoms after presumed tick-bite exposure compared to those in patients with confirmed acute neuroborreliosis

Nilsson K., Skoog E., Edvinsson M. et al.

Obesity, 2022
Proteomics, dietary intake, and changes in cardiometabolic health within a behavioral weight‐loss intervention: A pilot study

Hill E., Siebert J., Yazza D. et al.

Scientific Reports, 2022
Discovery of four plasmatic biomarkers potentially predicting cardiovascular outcome in peripheral artery disease

Kremers B., Posma J., Heitmeier S. et al.

Journal for ImmunoTherapy of Cancer, 2022
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors

Davis E., Martin-Liberal J., Kristeleit R. et al.

Biomedicines, 2022
Quantitative Proteomics Indicate Radical Removal of Non-Small Cell Lung Cancer and Predict Outcome

Bodén E., Andreasson J., Hirdman G. et al.

Journal of Proteome Research, 2022
Plasma Olink Proteomics Identifies CCL20 as a Novel Predictive and Diagnostic Inflammatory Marker for Preeclampsia

Wang X., Yip K., He A. et al.

Immunity, Inflammation and Disease, 2022
Exploratory analysis of interleukin‐38 in hospitalized COVID‐19 patients

de Graaf D., Teufel L., de Nooijer A. et al.

Nature Genetics, 2022
Multiomics study of nonalcoholic fatty liver disease

Sveinbjornsson G., Ulfarsson M., Thorolfsdottir R. et al.

Nature Communications, 2022
Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma

Rabold K., Zoodsma M., Grondman I. et al.

Rheumatology, 2022
Analyses of plasma inflammatory proteins reveal biomarkers predictive of subsequent development of giant cell arteritis: a prospective study

Wadström K., Jacobsson L., Mohammad A. et al.

Nature Communications, 2022
Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke

Chen L., Peters J., Prins B. et al.